Intensity Therapeutics, Inc. (INTS)
NASDAQ·Healthcare·Biotechnology
$5.21
-0.38%
Mkt Cap $14.65M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
-4.0%
Consensus $5.00 vs current $5.21
NASDAQ·Healthcare·Biotechnology
$5.21
-0.38%
Mkt Cap $14.65M
No recent rating data.
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
-4.0%
Consensus $5.00 vs current $5.21